GSK to increase R&D spending in Korea

Published: 2010-11-09 07:00:00

Updated: 2010-11-09 07:00:00

The U.K. based GlaxoSmithKline plans to increase its investment to develop new drugs in Korea because its Korean operation carries out an increasing number of multinational clinical tests, and because GSK is already partnering with Dong-A Pharmaceutical Co.

In a media invitation event in Hong Kong, Christophe Weber, Senior Vice President & Regional Director of Asia Pacific, GlaxoSmithKline s...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.